Cancer mortality rates have decreased by 34% overall, but incidence rates for women of all ages continue to rise, according ...

More than half (53%) of patients reached remission after one year of Omvoh treatment and 46% experienced healing of the ...

The GLP-1 [glucagon-like peptide 1] agents are poised to become viable options for treating indications beyond type 2 ...

Berge will serve in this role through the end of 2026, marking another milestone in her successful career in healthcare.

In 2024, UnitedHealth Group saw full year revenue grow 8% over 2023 to reach $400.3 billion. Adjusted earnings from ...

The 1.0 era of isolated telehealth is finally dead. We’re thrilled to welcome the new era of connected telehealth. In this ...

The investigational drug, called PMD-026, is currently in phase 2 clinical trials for the treatment of breast cancer.

Health plans in 2025 will pay more attention to cybersecurity. While the majority of hacks and breaches target healthcare ...

In an investor call, Andrew Witty promised full transparency and 100% pass-through rebates for prescription drugs by 2028.

By narrowing their research to overweight and obese individuals, Roswell Park researchers found that metformin might offer ...

The risk for lung cancer is especially high among those with rheumatoid arthritis who also have interstitial lung disease.

Conventional drug development typically zeroes in on individual proteins or signaling pathways. By focusing on the ...